We also verified that FFA mediated relaxation of ASMCs by activating TAS2R14 signaling pathway and opening BKCa channels, and the efficacy of FFA was similar to that of conventional β-agonist to relax ASMCs and abrogate airway resistance in animal models of asthma. This evidence concerns the gene TAS2R14 and asthma.